FAP, May 31 (FAP)-- as of press release, clover-B (02197.HK) fell 7.14%. The company has fallen from HK $12.98 at the beginning of its listing to around HK $1 today, and its share price has fallen by more than 90 per cent. This may be related to the fact that its COVID-19 business is not as expected. According to a recent announcement, the company announced that it will give priority to allocating all resources to the COVID-19 vaccine project and suspend further investment in SCB-313 (TRAIL- trimer tumor product), SCB-808 and SCB-420 (Fc fusion protein project).